THE PHOSPHODIESTERASE-4 (PDE4) INHIBITOR ROLIPRAM DECREASES ETHANOL SEEKING AND CONSUMPTION IN ALCOHOL-PREFERRING FAWN-HOODED RATS

被引:0
|
作者
Wen, R. T. [1 ]
Zhang, M. [1 ]
Qin, W. J. [1 ]
Liu, Q. [1 ]
Wang, W. P. [1 ]
Lawrence, A. J. [2 ]
Zhang, H. T. [3 ]
Liang, J. H. [1 ]
机构
[1] Peking Univ, Natl Inst Drug Depend, Beijing 100191, Peoples R China
[2] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3010, Australia
[3] W Virginia Univ, Hlth Sci Ctr, Morgantown, WV 26506 USA
关键词
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
引用
收藏
页码:352A / 352A
页数:1
相关论文
共 46 条
  • [41] Effects of the Novel Inhaled Phosphodiesterase-4 (PDE4) Inhibitor CHF6001 in Targeting Markers of Inflammation in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
    Singh, D.
    Govoni, M.
    Beeh, K. M.
    Colgan, B.
    Kornmann, O.
    Leaker, B.
    Watz, H.
    Lucci, G.
    Geraci, S.
    Rocco, E. Calabro
    Emirova, A.
    Nandeuil, M. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [42] ME3183, a novel phosphodiesterase-4 (PDE4) inhibitor, showed potent suppressive effects on pathogenic cytokine expression in cultures of peripheral blood mononuclear cells (PBMC) from psoriasis patients and on psoriatic features in mouse models
    Okura, I.
    Kaji, C.
    Kano, A.
    Tada, Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S98 - S98
  • [43] The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNF alpha) production in mice: Effect of adrenalectomy
    Cheng, JB
    Watson, JW
    Pazoles, CJ
    Eskra, JD
    Griffiths, RJ
    Cohan, VL
    Turner, CR
    Showell, HJ
    Pettipher, ER
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 280 (02): : 621 - 626
  • [44] OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled study
    Hanifin, Jon M.
    Ellis, Charles N.
    Frieden, Ilona J.
    Foelster-Holst, Regina
    Gold, Linda F. Stein
    Secci, Angelo
    Smith, Angela J.
    Zhao, Cathy
    Kornyeyeva, Elena
    Eichenfield, Lawrence F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (02) : 297 - 305
  • [45] Chronic alcohol consumption increases phosphodiesterase 4B (PDE4B) expression, decreases cellular camp levels and primes monocytes leading to augmented LPS-inducible TNF expression: Relevance to alcoholic liver disease
    Gobejishvili, Leila
    Barve, Shirish
    Joshi-Barve, Swati
    Song, Zhenyuan
    McClain, Craig J.
    HEPATOLOGY, 2006, 44 (04) : 594A - 595A
  • [46] The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems
    Cowen, MS
    Djouma, E
    Lawrence, AJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (02): : 590 - 600